Ritholtz Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Buy |
68,204
+16,691
| +32% | +$641K | 0.06% | 230 |
|
|
2025
Q1 | $2M | Sell |
51,513
-20,420
| -28% | -$791K | 0.06% | 251 |
|
|
2024
Q4 | $2.43M | Sell |
71,933
-6,607
| -8% | -$223K | 0.07% | 193 |
|
|
2024
Q3 | $3.21M | Buy |
78,540
+2,143
| +3% | +$87.6K | 0.1% | 145 |
|
|
2024
Q2 | $2.94M | Sell |
76,397
-1,147
| -1% | -$44.2K | 0.1% | 144 |
|
|
2024
Q1 | $3.32M | Buy |
77,544
+21,497
| +38% | +$922K | 0.11% | 123 |
|
|
2023
Q4 | $2.08M | Sell |
56,047
-994
| -2% | -$36.8K | 0.08% | 162 |
|
|
2023
Q3 | $2.07M | Buy |
57,041
+881
| +2% | +$31.9K | 0.09% | 135 |
|
|
2023
Q2 | $2M | Sell |
56,160
-5,981
| -10% | -$213K | 0.09% | 142 |
|
|
2023
Q1 | $2.21M | Sell |
62,141
-9,881
| -14% | -$352K | 0.11% | 117 |
|
|
2022
Q4 | $2.53M | Buy |
72,022
+28,322
| +65% | +$995K | 0.14% | 102 |
|
|
2022
Q3 | $1.29M | Buy |
43,700
+9,916
| +29% | +$292K | 0.07% | 199 |
|
|
2022
Q2 | $1.84M | Buy |
33,784
+9,536
| +39% | +$519K | 0.12% | 103 |
|
|
2022
Q1 | $1.32M | Buy |
24,248
+6,985
| +40% | +$380K | 0.09% | 139 |
|
|
2021
Q4 | $952K | Buy |
17,263
+6,369
| +58% | +$351K | 0.06% | 176 |
|
|
2021
Q3 | $520K | Buy |
10,894
+1,235
| +13% | +$59K | 0.04% | 260 |
|
|
2021
Q2 | $481K | Buy |
9,659
+2,975
| +45% | +$148K | 0.03% | 257 |
|
|
2021
Q1 | $298K | Buy |
6,684
+2,158
| +48% | +$96.2K | 0.02% | 304 |
|
|
2020
Q4 | $208K | Sell |
4,526
-780
| -15% | -$35.8K | 0.02% | 336 |
|
|
2020
Q3 | $250K | Sell |
5,306
-1,211
| -19% | -$57.1K | 0.03% | 234 |
|
|
2020
Q2 | $332K | Buy |
+6,517
| New | +$332K | 0.04% | 162 |
|